Status:
COMPLETED
To Assess Adherence to the Treatment and Quality of Life in Patients With Hypertension
Lead Sponsor:
AstraZeneca
Conditions:
Hypertension
Eligibility:
All Genders
21+ years
Brief Summary
The main goal of this study is to achieve a deeper knowledge of the adherence to antihypertensive drug treatment and to evaluate the quality of life in this population. This work has the following goa...
Eligibility Criteria
Inclusion
- Patients with diagnosis of essential hypertension under the criteria established by the Joint National Committee VII (9) and those patients under pharmacological treatment with the same therapeutic regime during at le
Exclusion
- Patients with secondary HBP
- Pregnant women or nursing mothers
- Patients with acute illnesses or having a definite psychiatric diagnosis, as well as those patients who are unable to completed
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
1150 Patients enrolled
Trial Details
Trial ID
NCT00944489
Start Date
August 1 2009
End Date
January 1 2010
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Buenos Aires, Argentina